Bone Biologics

BBLG · NASDAQ

$0.43+$0.0195 (+4.75%)TodayMarket closed · Oct 20, 5:57 PM ET

Prev close $0.4105

Latest news

NewsSep 17, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsAug 26, 5:07 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsAug 12, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsAug 12, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 12, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseJul 23, 8:00 AM ETGlobe Newswire
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
NewsMar 3, 1:07 PM ET
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.20/Share Price Valuation
NewsFeb 24, 4:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseJan 8, 8:00 AM ETGlobe Newswire
Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
NewsNov 17, 12:05 PM ET
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation
NewsSep 5, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseSep 4, 7:00 AM ETBusiness Wire
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
Press releaseSep 3, 7:00 AM ETBusiness Wire
Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
NewsAug 19, 8:08 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseJun 30, 4:10 PM ETBusiness Wire
Bone Biologics Announces Closing of $5.0 Million Public Offering
Press releaseJun 27, 9:10 AM ETBusiness Wire
Bone Biologics Announces Pricing of $5.0 Million Public Offering
NewsJun 27, 8:07 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsJun 27, 7:22 AM ET
Market-Moving News for June 27th
Press releaseJun 27, 7:00 AM ETBusiness Wire
Bone Biologics Files Patent Application for Bone Regeneration Technology
Press releaseJun 26, 4:20 PM ETBusiness Wire
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
Press releaseJun 6, 8:00 AM ETBusiness Wire
Bone Biologics Announces 1-for-6 Reverse Stock Split
NewsMay 13, 12:15 PM ET
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
NewsFeb 27, 11:05 AM ET
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation
Press releaseOct 21, 8:00 AM ETBusiness Wire
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
NewsSep 17, 5:48 AM ETAvi Kapoor
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
NewsSep 16, 9:42 AM ETAvi Kapoor
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
Press releaseSep 4, 8:00 AM ETBusiness Wire
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
NewsAug 12, 12:10 PM ET
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.75 Price Valuation
Press releaseAug 2, 8:00 AM ETBusiness Wire
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
NewsAug 1, 10:15 AM ETAvi Kapoor
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
NewsAug 1, 8:32 AM ETAvi Kapoor
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
NewsJul 25, 6:36 AM ETAvi Kapoor
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
NewsJul 24, 1:26 PM ETAvi Kapoor
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
NewsJul 24, 10:17 AM ETAvi Kapoor
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.20/Share Price Valuation

12 Health Care Stocks Moving In Tuesday's After-Market Session

Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation

12 Health Care Stocks Moving In Friday's Intraday Session

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Bone Biologics Announces Closing of $5.0 Million Public Offering

Bone Biologics Announces Pricing of $5.0 Million Public Offering

12 Health Care Stocks Moving In Friday's Pre-Market Session

Market-Moving News for June 27th

Bone Biologics Files Patent Application for Bone Regeneration Technology

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Bone Biologics Announces 1-for-6 Reverse Stock Split

Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation

Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.50 Price Valuation

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $16.75 Price Valuation

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Nasdaq Surges 1%; Meta Posts Upbeat Earnings

Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Nasdaq Down 2%; Alphabet Posts Upbeat Earnings